Physician profile
Scott Cohen
NPI 1497843288
$5,949.50
in general payments reported to CMS, 2019-2025
37 companies · $803 in 2025
The $803 reported for 2025 was more than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $768 · 2020: $522 · 2021: $954 · 2022: $781 · 2023: $935 · 2024: $1,187 · 2025: $803.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,896 · Education: $29.44.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,895.77 |
| Education | $29.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,577.81 | 2019-2025 | Linzess, Viberzi, Creon |
| Janssen Biotech, INC. | $1,000.65 | 2019-2025 | Stelara, Tremfya, Simponi Aria |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $568.83 | 2019-2025 | Xifaxan, Trulance, Plenvu |
| Takeda Pharmaceuticals U.S.A., INC. | $464.09 | 2019-2025 | Entyvio, Gattex, Eohilia |
| Nestle Healthcare Nutrition INC. | $348.56 | 2020-2023 | |
| Ardelyx, INC. | $214.60 | 2023-2025 | Ibsrela |
| Genzyme Corporation | $163.53 | 2022-2025 | |
| Celgene Corporation | $138.93 | 2021-2023 | Zeposia |
| Merck Sharp & Dohme LLC | $135.63 | 2019-2021 | |
| Medtronic, INC. | $126.22 | 2025 | Endoflip |
| Gilead Sciences, INC. | $121.58 | 2019-2025 | |
| Intercept Pharmaceuticals, INC. | $115.60 | 2020-2025 | Ocaliva |
| Phathom Pharmaceuticals, INC. | $112.50 | 2024-2025 | Voquezna |
| Pharmacosmos Therapeutics INC. | $93.08 | 2021 | |
| Ipsen Biopharmaceuticals, INC | $83.51 | 2024-2025 | Iqirvo |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $58.94 | 2024-2025 | Omvoh |
| Allergan, INC. | $50.83 | 2019-2020 | |
| Daiichi Sankyo INC. | $50.12 | 2019-2025 | Enhertu |
| Regeneron Healthcare Solutions, INC. | $47.77 | 2023-2025 | Dupixent |
| Redhill Biopharma INC. | $43.85 | 2020-2021 | |
| Concordia Pharmaceuticals INC. | $42.70 | 2019 | |
| Qol Medical, LLC | $41.15 | 2023 | Sucraid |
| Laborie Medical Technologies Corp. | $38.40 | 2024 | |
| Madrigal Pharmaceuticals | $34.51 | 2024-2025 | Resmetirom, Rezdiffra |
| Evoke Pharma, INC. | $32.53 | 2021 | |
| Intra-Sana Laboratories | $29.22 | 2023-2024 | Reltone 400 Mg, Glycate, Reltone 200 Mg |
| Alfasigma USA, INC. | $28.16 | 2020-2021 | |
| Shire North American Group INC | $26.07 | 2019 | |
| Romark Laboratories, Lc | $23.48 | 2020 | |
| Exact Sciences Corporation | $22.53 | 2025 | Cologuard Collection Kit |
| Vivus LLC | $21.94 | 2019 | |
| Olympus America INC. | $20.57 | 2024 | Evis Exera III Colonovideoscope |
| Aimmune Therapeutics, INC. | $19.96 | 2025 | Zenpep |
| Pfizer INC. | $16.04 | 2023 | |
| Celltrion USA INC. | $14.62 | 2024 | Zymfentra |
| Ironwood Pharmaceuticals, INC | $11.49 | 2019 | |
| Micro-Tech Endoscopy USA, INC. | $9.50 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Cohen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.